Autolus Therapeutics Appoints Ryan Richardson to Board of Directors [Yahoo! Finance]
Autolus Therapeutics Appoints Ryan Richardson to Board of Directors
NICE Recommends AUCATZYL® (obecabtagene autoleucel) as a Treatment Option for Adult Patients (=26 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)¹
Autolus Therapeutics plc (NASDAQ:AUTL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year [Yahoo! Finance]
Autolus Therapeutics: Trading At Cash Is Not Justified With This Pipeline [Seeking Alpha]